2013
DOI: 10.1007/978-3-642-38718-0_20
|View full text |Cite
|
Sign up to set email alerts
|

Automatic Generation of the HPC Challenge’s Global FFT Benchmark for BlueGene/P

Abstract: Abstract. We present the automatic synthesis of the HPC Challenge's Global FFT, a large 1D FFT across a whole supercomputer system. We extend the Spiral system to synthesize specialized single-node FFT libraries that combine a data layout transformation with the actual on-node FFT computation to improve the network performance through enabling all-to-all collectives. We run our optimized Global FFT benchmark on up to 128k cores (32 racks) of ANL's BlueGene/P "Intrepid" and achieved 6.4 Tflop/s, outperforming A… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
2
1
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 16 publications
0
1
0
Order By: Relevance
“…Also, the affinities at A 1 AR and A 2A AR were higher with the (N)methanocarba pseudoribose ring. Also, nucleosides containing a 2′-methyl group, which favors a (N) conformation, were more potent at ARs than those with a 3′-methyl group [22]. At the P2Y 1 R, the (N)-methanocarba modification enhances the affinity of both agonists and antagonists, and (N)-methanocarba nucleotide antagonist MRS2500 is present in P2Y 1 R Xray structure (with residue name 2ID) [20,24].…”
Section: Purinergic Receptorsmentioning
confidence: 99%
“…Also, the affinities at A 1 AR and A 2A AR were higher with the (N)methanocarba pseudoribose ring. Also, nucleosides containing a 2′-methyl group, which favors a (N) conformation, were more potent at ARs than those with a 3′-methyl group [22]. At the P2Y 1 R, the (N)-methanocarba modification enhances the affinity of both agonists and antagonists, and (N)-methanocarba nucleotide antagonist MRS2500 is present in P2Y 1 R Xray structure (with residue name 2ID) [20,24].…”
Section: Purinergic Receptorsmentioning
confidence: 99%